比较单次激发回波平面成像扩散加权MRI与快速自旋回波信号分裂采集非EPI技术在头颈部肿瘤中的应用
回顾性分析55例头颈部良恶性病变和74例治疗后鳞状细胞癌扫描,DW-SPLICE在图像质量和畸变上优于DWI-EPI,ADC测量信度高但存在比例偏倚,1年复发识别更准确而6个月无差异,建议随访中固定使用同一种方法。
要点
- DW-SPLICE在头颈部图像质量和整体畸变上优于DWI-EPI(0.04<P<.001)。
- 两种技术ADC值不可完全互换,随访应固定使用同一种DWI方法。
- DW-SPLICE在1年随访时识别复发更准确(OR=0.96,P=.05),6个月无差异。
核心结论
- DW-SPLICE在图像畸变和质量上优于DWI-EPI,并提高3T头颈部MRI检测复发或残留鳞状细胞癌的诊断可靠性。
- 建议随访中固定使用同一种DWI方法,因为ADC值不可完全互换。
- 将DW-SPLICE整合入临床实践可显著改善肿瘤评估。
研究设计与样本
- 回顾性分析两个亚组:良恶性病变组55例扫描(55例患者),治疗后鳞状细胞癌组74例扫描(66例患者)。
- DW-SPLICE序列被纳入标准3T头颈部MRI方案(含DWI-EPI)。
- 由2名对DWI技术不知情的独立放射科医师评分图像质量和畸变,采用混合效应线性模型分析。
- 采用组内相关系数和Bland-Altman分析评估病灶ADC值,采用DSC评估DWI与T1加权增强MRI的勾画几何相似性。
- 由同2名对DWI技术不知情的放射科医师评估治疗后鳞状细胞癌扫描的复发,采用混合逻辑回归比较两种技术的复发检出率(随访6个月和1年数据)。
关键影像表现/征象
- DW-SPLICE在图像质量评分上优于DWI-EPI,整体畸变较少(0.04<P<.001)。
- DW-SPLICE在配准前与钆对比剂T1WI的几何相似性更高(DSC 0.63 vs 0.47,P<.001)。
诊断标准与关键数值
- ADC测量信度高(组内相关系数=0.93,P<.001),但存在比例偏倚(β=0.11,P=.03),偏倚随ADC值增大而增加。
- DW-SPLICE在1年随访时识别复发优于DWI-EPI(OR=0.96,P=.05),6个月随访时无显著差异(OR=0.72,P=.13)。
临床应用与阅片要点
- DW-SPLICE可作为DWI-EPI的可行替代方案用于3T头颈部MRI,以减少空气腔和牙科填充物周围的畸变。
- 随访中应固定使用同一种DWI方法,因两种技术的ADC值不可完全互换。
- 将DW-SPLICE整合入临床实践可显著改善肿瘤评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: DWI using single-shot echo-planar imaging (DWI-EPI) is susceptible to distortions around air-filled cavities and dental fillings, typical for the head and neck area. Non-EPI, split acquisition of fast spin-echo signals for diffusion imaging (DW-SPLICE) could reduce these distortions and enhance image quality, thereby potentially improving recurrence assessment in squamous cell carcinoma (SCC) of the head and neck region. This study evaluated whether DW-SPLICE is a viable alternative to DWI-EPI through quantitative and qualitative analyses.
MATERIALS AND METHODS: The DW-SPLICE sequence was incorporated into the standard 3T head and neck MRI protocol with DWI-EPI. Retrospective analysis was conducted on 2 subgroups: first benign or malignant lesions, and second, posttreatment SCC recurrence. In both subgroups, image quality and distortion were scored by 2 independent radiologists, blinded to the DWI technique and evaluated using mixed-effect linear models. Lesion ADC values were assessed with interclass correlation and Bland-Altman analyses. The delineation geometric similarity of DWI to T1-weighted postcontrast MRI was evaluated using the DSC before and after registration. Recurrence in posttreatment SCC scans was evaluated by the same 2 radiologists blinded to the DWI technique. Recurrence detection rates were then compared between DW-SPLICE and DWI-EPI using mixed logistic regression at 6 months and 1 year postscan follow-up data.
RESULTS: From August 2020 to January 2022, fifty-five benign or malignant lesion scans (55 patients) and 74 posttreatment SCC scans (66 patients) were analyzed. DW-SPLICE scored better on image quality and showed less overall distortion than DWI-EPI (0.04<P < .001). There was high ADC measurement reliability (intraclsss correlation coefficient = 0.93, P < .001), though a proportional bias was also observed (β = 0.11, P = .03), indicating that the bias increases as ADC values increase. DW-SPLICE exhibited greater geometric similarity to T1WI with gadolinium contrast before registration (DSC 0.63 versus 0.47, P < .001) and outperformed DWI-EPI by more accurately identifying recurrences after 1 year (OR = 0.96, P = .05) but not after 6 months (OR = 0.72, P = .13).
CONCLUSIONS: DW-SPLICE surpasses DWI-EPI on image distortion and quality and improves diagnostic reliability for detecting recurrent or residual SCC on 3T MRI of the head and neck. Consistent use of 1 method for follow-up is advised, because ADC values are not completely interchangeable. Integrating DW-SPLICE can significantly improve tumor assessments in clinical practice.
引用
- van der Hulst HJ, Braun L, Westerink B, et al. Comparison of Diffusion-Weighted MRI Using Single-Shot Echo-Planar Imaging and Split Acquisition of Fast Spin-Echo Signal Imaging, a Non-EPI Technique, in Tumors of the Head and Neck. AJNR Am J Neuroradiol. 2025. PMID: 39384329. doi:10.3174/ajnr.A8529
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。